Results 51 to 60 of about 534 (117)

ID029 Monitoramento do Horizonte Tecnológico: Ozanimode para o tratamento da esclerose múltipla

Jornal de Assistência Farmacêutica e Farmacoeconomia
Introdução A Esclerose Múltipla (EM) é uma doença desmielinizante, incurável, inflamatória e imunomediada do sistema nervoso central (SNC), que acomete principalmente jovens adultos na faixa etária dos 20 a 50 anos.
Kelli Carneiro de Freitas Nakata, Cristiane Rocha de Oliveira, Diana Lima dos Santos, Grasiela Martins da Silva, Luisa Daige Marques, Maria Cristina de Camargo, Quenia Cristina Dias Morais, Rosa Camila Lucchetta, Verônica Clemente   +8 more
doaj   +1 more source

Cognitive impairment in multiple sclerosis: "classic" knowledge and recent acquisitions. [PDF]

Arq Neuropsiquiatr, 2023
Piacentini C, Argento O, Nocentini U.
europepmc   +1 more source

The clinical-radiological paradox in multiple sclerosis: myth or truth? [PDF]

Arq Neuropsiquiatr, 2023
Hartmann A, Noro F, Bahia PRV, Fontes-Dantas FL, Andreiuolo RF, Lopes FCR, Pereira VCSR, Coutinho RA, Araujo AD, Marchiori E, Alves-Leon SV.   +10 more
europepmc   +1 more source

Tracking the impact of multiple sclerosis on employment status: the development of a questionnaire. [PDF]

Arq Neuropsiquiatr, 2022
Cores EV, Steinberg J, Cuesta C, Curbelo MC, Osorio MA, Bauer JJ, Politis DG.   +6 more
europepmc   +1 more source

Flow volume measurement of arterial venous and cerebrospinal fluid in patients with multiple sclerosis. [PDF]

Arq Neuropsiquiatr, 2022
Aglamis S, Gönen M.
europepmc   +1 more source

Correlation of brain segmental volume changes with clinical parameters: a longitudinal study in multiple sclerosis patients. [PDF]

Arq Neuropsiquiatr, 2023
Eskut N, Koc AM, Koskderelioglu A, Dilek I, Tekindal MA.   +4 more
europepmc   +1 more source

Serum levels of irisin and nesfatin-1 in multiple sclerosis. [PDF]

Arq Neuropsiquiatr, 2022
Altas M, Uca AU, Akdag T, Odabas FO, Tokgoz OS.   +4 more
europepmc   +1 more source

Association between clinical evaluation and self perception of deglutition with motor disability scale in patients with multiple sclerosis. [PDF]

Codas, 2022
Piloti DTW, Ruiz VCD, Ribeiro MC, Almeida ST.   +3 more
europepmc   +1 more source

Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach. [PDF]

Arq Neuropsiquiatr, 2022
Gomes ABAGR, Feo LB, Silva GD, Disserol CCD, Paolilo RB, Lara AN, Tonácio AC, Mendes MF, Pereira SLA, Callegaro D.   +9 more
europepmc   +1 more source

Esclerose múltipla

Arquivos de Neuro-Psiquiatria, 2005
Antonio Spina-França
doaj   +1 more source